Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $3.32 USD
Change Today -0.12 / -3.49%
Volume 1.0M
IDRA On Other Exchanges
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Louis J. Arcudi III, MBA

Chief Financial Officer, Principal Accounting Officer, Senior Vice President of Operations, Secretary and Treasurer, Idera Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Mr. Louis J. Arcudi, III, also known as Lou, has been the Chief Financial Officer of Idera Pharmaceuticals, Inc. since December 3, 2007. Mr. Arcudi has been Senior Vice President of Operations at Idera Pharmaceuticals, Inc. since April 2011. He has been Secretary and Treasurer at Idera Pharmaceuticals, Inc. since December 2007 and serves as its Principal Accounting Officer. Mr. Arcudi served as Corporate Controller and Senior Director of Finance &Administration of Peptimmune, ...

Read Full Background

Corporate Headquarters*

167 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-679-5500
Fax: 617-679-5592

Board Members Memberships*

There is no Board Members Memberships data available.


Bryant University
Southern New Hampshire University
The University of New Hampshire, Durham

Other Affiliations*

Annual Compensation*

Total Annual Compensation$409,500

Stock Options*

All Other Compensation$31,033
Exercisable Options399,250
Exercisable Options Value$475,017
Unexercisable Options720,083
Unexercisable Options Value$2,205,024
Total Value of Options$2,680,040
Total Number of Options1,119,333

Total Compensation*

Total Annual Cash Compensation$440,533
Total Short Term Compensation$409,500
Other Long Term Compensation$31,033
Total Calculated Compensation$1,022,490
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDRA:US $3.32 USD -0.12


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDERA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at